Matthew Hall

Associate Clinical Professor

Florida International University
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (25)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Background Radiation therapy (RT) offers pain relief for patients with symptomatic spine metastases. This study compares pain response and quality of life (QOL) between conventional RT or RT and radiofrequency ablation/percutaneous vertebral augmentation (RFA/PVA). Methods This single-center, prospective, randomized phase 2 trial (NCT04375891) enrolled patients with spine metastasis (T5-L5, with 1-2 index sites amenable to RFA) and a minimum Numeric Pain Rating Scale (NPRS) of 5. After stratifying by tumor type (radioresistant vs. radiosensitive), patients were randomized (1:2) to RT or RT+RFA/PVA. The primary endpoint was 3-month pain response. Secondary endpoints included rapidity and duration of pain response, adverse events, and QOL measures. Results The study terminated after enrolling and randomizing 63 patients (79% of planned accrual; 21 RT alone, 42 RT+RFA/PVA). The median baseline NPRS was 10 (interquartile range [IQR] 8-10) for RT and 9 (7.5-10) for RT+RFA/PVA. The primary endpoint of pain control 3 months after treatment was similar between the RT and RT+RFA/PVA arms (50% vs. 48%, P = .92). Complete pain response rates at 3 months were also similar in the RT and RT+RFA/PVA arms (17% vs. 21%, P = .77). The 3-month median NPRS reduction was −4 (IQR, −6 to −1) in both the RT and the RT+RFA/PVA arms. Secondary efficacy endpoints and toxicity rates were comparable. Overall QOL measures including FACT-G, BPI, and EQ-5D scores were also similar between the two treatment arms. Conclusions The addition of RFA/PVA to conventional RT for patients with symptomatic spine metastases did not improve pain control or QOL measures at 3 months.

Year:

2026

Year:

2025

Background Stereotactic radiosurgery (SRS) for patients with brain metastases (BM) is associated with a risk of distant intracranial failure (DIF). This study evaluates the impact of integrating dedicated 3D fast/turbo spin echo (3D-TSE) sequences to MPRAGE in BM detection and DIF prolongation in a histology-agnostic patient cohort. Methods The study population included adults treated with SRS from February 2019 to January 2024 who underwent MPRAGE alone or dual sequence with the addition of 3D-TSE starting from February 2020. Median times to DIF were estimated using the Kaplan–Meier method. Results The 216 study patients who underwent 332 SRS courses for 1456 BM imaged with MPRAGE and 3D-TSE (primary cohort) were compared to a control cohort (92 patients, 135 SRS courses, 462 BM). In the session-wise analysis, the median time to DIF between the cohorts was significantly prolonged in the primary vs. control cohorts (11.4 vs. 6.8 months, P = .029), more pronounced in the subgroups with 1–4 metastases (14.7 vs. 8.1 months, P = .008) and with solitary BM (36.4 vs. 10.9 months, P = .001). While patients relapsing on immunotherapy or targeted therapy did not significantly benefit from 3D-TSE (7.2 vs. 5.7 months, P = .280), those who relapsed on chemotherapy or who were off systemic therapy (including synchronous metastases) exhibited a trend toward longer time to DIF with 3D-TSE integration (14.7 vs. 7.9 months, P = .057). Conclusions Implementing 3D-TSE sequences into SRS practice increases BM detection across all patients and translates into clinical relevance by prolonging time to DIF, particularly in those with limited intracranial disease and those not receiving central nervous system-active agents.

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Collaborators (32)

Chandan Kumar

Associate Research Scientist

University of Michigan

UNITED STATES
View details

Adam Resnick

Director

University of Pennsylvania

UNITED STATES
View details

Sebastian Waszak

Tenure Track Assistant Professor

University of California, San Francisco

UNITED STATES
View details

Mariella Filbin

Dana-Farber Cancer Institute

UNITED STATES
View details

Arul M Chinnaiyan

University of Michigan

UNITED STATES
View details

Yoshie Umemura

Barrow Neurological Institute

UNITED STATES
View details

Muni Rubens

Florida International University Herbert Wertheim College of Medicine

UNITED STATES
View details

Rajen J. Mody

University of Michigan

UNITED STATES
View details

Heather McCrea

Assistant Professor

University of Miami

UNITED STATES
View details

minesh mehta

Chair

Florida International University

UNITED STATES
View details

Anna Schwendeman

-

UNITED STATES
View details

Timothy Cloughesy

Director of NeuroOncology Program/Professor

Ronald Reagan UCLA Medical Center

UNITED STATES
View details

Michelle M Kim

University of Michigan

UNITED STATES
View details

Sriram Venneti

Professor

University of Michigan

UNITED STATES
View details

Lili Zhao

Professor

Northwestern University

UNITED STATES
View details

Charles Burant

University of Michigan

UNITED STATES
View details

Sabine Mueller

Adjunt Associate Professor

University of California

UNITED STATES
View details

Nathalie Agar

Principal Investigator

Brigham and Women's Hospital

UNITED STATES
View details

Nicholas Borja

Assistant Professor of Clinical Genetics

University of Miami Miller School of Medicine

UNITED STATES
View details

Rajan Jain

Professor

NYU Langone Health

UNITED STATES
View details

Matthew Dun

Professor Paediatric Heamatology/Oncology Research

Hunter Medical Research Institute

AUSTRALIA
View details

Susanne Schmidt

Group Leader

University of Bonn

GERMANY
View details

Carl Koschmann

University of Michigan Medical School

UNITED STATES
View details

Andrea T. Franson

-

UNITED STATES
View details

Javad Nazarian

Lead, DMG Research Center

-

SWITZERLAND
View details

Chan Chung

Principal investigator

Daegu Gyeongbuk Institute of Science and Technology

SOUTH KOREA
View details

Benjamin M Ellingson

Professor

University of California, Los Angeles

UNITED STATES
View details

Mustafa Tekin

University of Miami

UNITED STATES
View details

Daniel R. Wahl

University of Michigan

UNITED STATES
View details

Jacques Grill

Head day care

Gustave Roussy

FRANCE
View details

Costas A. Lyssiotis

University of Michigan

UNITED STATES
View details

Sharon L Gardner

Associate Professor (Clinical) of Pediatrics

NYU School of Medicine

UNITED STATES
View details